Oct 20, 2025
In this episode, Paul Goode (Glucotrack) dives into the next wave of continuous glucose monitoring: an active, fully implantable CGM designed to deliver long-term, pacemaker-style reliability without external wearables. We discuss first-in-human progress, why implantables may change diabetes care at home, and a fascinating neural angle—how similar chemistry and form factors could be adapted to epidural glucose sensing and even paired with neural recording electrodes to capture metabolic and neural data together. If you care about closed-loop systems, chronic implants, or bridging bioelectrochemistry with neurotech, this one’s for you.
Top 3 Takeaways:
1:15 Do you want to introduce yourself better than I just did?
2:15 Why was a glucose sensor company invited to come on the Neural Implant Podcast?
7:15 How many electrodes on a device would need to be used in order to measure glucose in the epidural space?
8:45 How do your glucose measurements compare with Continuous Glucose Monitors?
12:30 What's the company's next step?
16:00 Is there anything you would want of the Neural Implant community?